Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 283.45M
March 31, 2026 297.48M
December 31, 2025 297.37M
September 30, 2025 267.60M
June 30, 2025 239.96M
March 31, 2025 225.16M
December 31, 2024 220.80M
September 30, 2024 214.31M
June 30, 2024 218.04M
March 31, 2024 166.82M
December 31, 2023 145.15M
September 30, 2023 110.91M
June 30, 2023 95.33M
March 31, 2023 116.83M
December 31, 2022 114.29M
September 30, 2022 132.10M
June 30, 2022 121.58M
March 31, 2022 124.01M
December 31, 2021 147.23M
September 30, 2021 138.33M
June 30, 2021 168.49M
March 31, 2021 171.64M
December 31, 2020 165.27M
September 30, 2020 155.26M
June 30, 2020 115.34M
Date Value
March 31, 2020 93.17M
December 31, 2019 77.81M
September 30, 2019 74.58M
June 30, 2019 87.17M
March 31, 2019 92.10M
December 31, 2018 86.53M
September 30, 2018 82.19M
June 30, 2018 63.21M
March 31, 2018 55.48M
December 31, 2017 62.73M
September 30, 2017 60.65M
June 30, 2017 62.72M
March 31, 2017 57.19M
December 31, 2016 53.60M
September 30, 2016 48.79M
June 30, 2016 54.52M
March 31, 2016 61.77M
December 31, 2015 69.46M
September 30, 2015 78.74M
June 30, 2015 73.57M
March 31, 2015 64.64M
December 31, 2014 53.32M
September 30, 2014 49.33M
June 30, 2014 57.15M
March 31, 2014 56.44M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Globus Medical, Inc. 910.39M
Baxter International, Inc. 1.319B
DexCom, Inc. 1.749B
Haemonetics Corp. 328.15M
ICU Medical, Inc. 236.37M